SANOFI SYNTHELABO
Sanofi-Synthelabo Inc., a pharmaceutical company, provides products for physicians and patients in the healthcare industry. It focuses on various therapeutic areas, such as cardiovascular diseases and thrombosis, diseases of the central nervous system, internal medicine, and oncology. The company was incorporated in 1989 and is headquartered in New York, New York. Sanofi-Synthelabo Inc. operates as a subsidiary of Sanofi. Source: {Businessweek} (http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=4205385)
SANOFI SYNTHELABO
Industry:
Health Care Pharmaceutical Therapeutics
Address:
New York, New York, United States
Country:
United States
Status:
Active
Contact:
800-981-2491
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Domain Not Resolving Nginx Euro Organization Schema IPv6 JsDelivr
Current Advisors List
More informations about "Sanofi Synthelabo"
Sanofi - Wikipedia
Sanofi was founded in 15 February 1973 as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by Sociéte Belge de l'Azote et des Produits Chimiques du Marly; Labaz developed benziodarone in 1957. In 1993, Sanofi made a move into the Eastern Europe market by acquiring a controlling interest in Chinoin, a Hungarian drug company whose …See details»
Sanofi Synthelabo - Crunchbase Company Profile
Sanofi-Synthelabo Inc., a pharmaceutical company, provides products for physicians and patients in the healthcare industry. It focuses on various …See details»
The Sanofi-Synthélabo Group - Encyclopedia.com
Sanofi Group is formed as a subsidiary of Elf Aquitaine. 1981: Sanofi forms joint subsidiary with American Home Products. 1983: Sanofi opens biotechnology center in Lab è ge, France. …See details»
Our Company - Sanofi U.S.
The Sanofi of today is built on a heritage of turning the impossible into the possible for people and communities around the globe. Our Legacy MAT-US-2400483-v1.0-01/2024See details»
Sanofi-Synthelabo LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sanofi-Synthelabo LLC of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Sanofi-Synthelabo Inc - Company Profile and News
Company profile page for Sanofi-Synthelabo Inc including stock price, company news, executives, board members, and contact informationSee details»
Sanofi-Synthélabo — Wikipédia
Sanofi-Synthélabo est un groupe pharmaceutique français, né en 1999 de la fusion de Sanofi (alors filiale du groupe pétrolier Elf) et de Synthélabo (à l'époque filiale du groupe de …See details»
A look back at Sanofi’s merger with Synthélabo - PMLiVE
May 24, 2013 The Synthélabo deal took the pressure off, however, bolstering Sanofi’s sales and marketing activities and giving the company access to even more successful products, including Ambien (zolpidem) for insomnia. By 2000 …See details»
Our Company: Committed to Improving People's Lifes
The Sanofi of today is built on a heritage of turning the impossible into the possible for people and communities around the globe. Our Legacy. Our Pipeline. 5. Therapeutic areas. 86. Compounds in clinical development. 24. Clinical …See details»
Sanofi-Synthelabo, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Explore Sanofi-Synthelabo, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 17 news, and 12 literature, Disease Domain:Nervous System …See details»
Sanofi | Pharma 50 - Drug Discovery and Development
The company reverted its name back to Sanofi in 2011. In recent years, the company has pursued a series of bolt-on acquisitions, including six in 2021 to bolster its involvement in …See details»
Sanofi-Synthelabo SA Information - RocketReach
Sanofi-Synthelabo is a major global research-based pharmaceutical group with 32,500 employees in more than 100 countries and consolidated sales of over euro 8 billion in 2003. With an R&D …See details»
Sanofi-Synthélabo
Sanofi was a French pharmaceutical company created in 1973. Synthélabo was the pharmaceutical division of L'Oréal, the world's leading company in cosmetics and beauty. …See details»
Sanofi Canada: global healthcare and pharmaceutical company
Sanofi has strong foundations in Canada going back over a century, and operates world-leading R&D and biomanufacturing facilities in Toronto. Sanofi also operates an artificial intelligence AI …See details»
Sanofi-Synthélabo SA - Drug pipelines, Patents, Clinical trials
Explore Sanofi-Synthélabo SA with its drug pipeline, therapeutic area, technology platform, 235 clinical trials, 130 news, and 707 literature, Disease Domain:Neoplasms, Infectious Diseases, …See details»
Our Manufacturing and Supply Chain Network - Sanofi
Factory of The Future Awards 2023: Sanofi. Our Belgium colleagues in Geel received the 2023 Future of the year Award. Digital technology is used to collect data in conjunction with science …See details»
Sanofi-Synthelabo annual report 2001
Sanofi-Synthélabo's R&D organization, targeted on the group's four core therapeutic areas, uses state-of-the-art technologies. Sanofi-Synthélabo has a portfolio of 48 compounds in …See details»
The AI revolution: A conversation with Sanofi CEO | McKinsey
2 days ago Working with external AI partners, he’s pushing Sanofi to become the AI leader in its industry. What follows is an edited version of his conversation with McKinsey Senior Partners …See details»
Sanofi Explained
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France.The corporation was established in 1973 and merged with Synthélabo in 1999 to …See details»
Sanofi and Synthelabo Agree to Merge, Forming a Top 20 Global …
Dec 3, 1998 Under the deal, announced late Wednesday, Sanofi, a unit of French oil company Elf Aquitaine SA, and Synthelabo, a unit of cosmetics concern L'Oreal SA, will join forces in a …See details»